Observational studyJournal of pediatric gastroenterology and nutrition2026
Multiple switches between infliximab originator and biosimilars in pediatric inflammatory bowel disease.
Sofie De Groote et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.